CompletedNot Applicable

The Role of Cerebral NIRS in Preventing Brain Injury of Very Low Birth Weight Preterm Infants

Indonesia129 participantsStarted 2017-05-01

Plain-language summary

This study determines the effectiveness of cerebral Near Infrared Spectroscopy (NIRS) as a monitoring device combined with a SafeboosC treatment guideline in order to prevent brain injury in very low birth weight preterm neonates. Each experimental and control groups consists of at least 30 participants, and only the experimental group uses cerebral NIRS and a treatment guideline.

Who can participate

Age range3 Days

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

* Inclusion Criteria: * Neonates born in dr. Cipto Mangunkusumo Hospital and admitted in the neonatal intensive care unit * Gestational age ≤ 32 weeks and/or birth weight ≤ 1500grams * Exclusion Criteria: * Parents refuse to participate * Participants who are not able to use cerebral NIRS in the first 3 hours of life * Participants with congenital malformation and cerebral complications during delivery * Participants who are diagnosed with IVH/PVL in the first 3 hours of life (confirmed with brain ultrasonography examination and assessed by radiology pediatric specialist)

What they're measuring

72 hours preterm brain injury

Timeframe: 72 hours

Trial details

NCT IDNCT06729398

SponsorDr Cipto Mangunkusumo General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-05-01

View on ClinicalTrials.gov More Neonatal Cerebral Leukomalacia trials